Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
Open Access
- 4 March 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5), 2590
- https://doi.org/10.3390/ijms22052590
Abstract
Fibrinogen is a well-known risk factor for arterial and venous thrombosis. Its function is not restricted to clot formation, however, as it partakes in a complex interplay between thrombin, soluble plasma fibrinogen, and deposited fibrin matrices. Fibrinogen, like thrombin, participates predominantly in hemostasis to maintain vascular integrity, but executes some important pleiotropic effects: firstly, as observed in thrombin generation experiments, fibrin removes thrombin from free solution by adsorption. The adsorbed thrombin is protected from antithrombins, notably α2-macroglobulin, and remains physiologically active as it can activate factors V, VIII, and platelets. Secondly, immobilized fibrinogen or fibrin matrices activate monocytes/macrophages and neutrophils via Mac-1 interactions. Immobilized fibrin(ogen) thereby elicits a pro-inflammatory response with a reciprocal stimulating effect of the immune system on coagulation. In contrast, soluble fibrinogen prohibits recruitment of these immune cells. Thus, while fibrin matrices elicit a procoagulant response, both directly by protecting thrombin and indirectly through the immune system, high soluble fibrinogen levels might protect patients due to its immune diminutive function. The in vivo influence of the ‘protective’ plasma fibrinogen versus the ‘pro-thrombotic’ fibrin matrices on thrombosis should be explored in future research.This publication has 140 references indexed in Scilit:
- Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemiaBlood, 2013
- Hepatic acute phase proteins – Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signalingEuropean Journal of Cell Biology, 2012
- Assessment of Genetic Determinants of the Association of γ′ Fibrinogen in Relation to Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative BacteriumYersinia enterocoliticaThe Journal of Immunology, 2011
- Streptococcal M1 protein constructs a pathological host fibrinogen networkNature, 2011
- A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteriesAtherosclerosis, 2009
- Reduced thrombin generation increases host susceptibility to group A streptococcal infectionBlood, 2009
- Antiadhesive effect of fibrinogen: a safeguard for thrombus stabilityBlood, 2006
- Staphylococcus aureus EndocarditisJAMA, 2005
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionThe New England Journal of Medicine, 1984